• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TISSUE SCIENCE LABORATORIES PELVILACE BIOURETHRAL SUPPORT SYSTEM; PAG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TISSUE SCIENCE LABORATORIES PELVILACE BIOURETHRAL SUPPORT SYSTEM; PAG Back to Search Results
Catalog Number 482150
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Pain (1994); Prolapse (2475)
Event Type  Injury  
Event Description
Per additional information received, the patient has experienced prolapse recurrence, constipation, urethral hypermobility, postmenopausal atrophic vaginitis, rectocele, cystocele, enterocele, atypical urothelial cells, sling that had migrated to the bladder neck, pain, erosion, extrusion, urinary problems, dyspareunia, emotional distress, and a loss of consortium.
 
Manufacturer Narrative
(b)(4).The sample was not returned.The finished product met all specifications prior to being released for general distribution.The instructions for use which accompanies all devices currently addresses potential risks associated with surgically implanted materials.The instructions for use states in the adverse events: potential complications associated with the proper implantation of the pelvilace biourethral support system may include, but are not limited to: postoperative hematoma.Temporary urinary retention, bladder outlet obstruction, and voiding difficulties associated with over-correction/too much tension placed on the implant.Perforations or lacerations of vessels, nerves, bladder or bowel, which may occur during needle passage.(b)(4).
 
Manufacturer Narrative
(b)(4).Initial reporting period: (b)(4) 2013 - (b)(4) 2013.
 
Manufacturer Narrative
(b)(4).Original reporting time frame november 1, 2013 ¿ december 31, 2013.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Manufacturer Narrative
(b)(4).Original reporting time frame november 1, 2013 through december 31, 2013.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Manufacturer Narrative
(b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Manufacturer Narrative
Exemption no.(b)(4).Original reporting time frame november 1, 2013 through december 31, 2013.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELVILACE BIOURETHRAL SUPPORT SYSTEM
Type of Device
PAG
Manufacturer (Section D)
TISSUE SCIENCE LABORATORIES
unit 1, astley lane industrial
swillington, leeds, LS26 8XT
UK  LS26 8XT
Manufacturer (Section G)
TISSUE SCIENCE LABORATORIES 3004086170
unit 1, astley lane industrial
swillington, leeds, LS26 8XT
UK   LS26 8XT
Manufacturer Contact
angela robinson
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key3596041
MDR Text Key4092135
Report Number1018233-2014-00020
Device Sequence Number1
Product Code PAG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042949
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,other
Reporter Occupation Attorney
Remedial Action Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 01/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/29/2012
Device Catalogue Number482150
Device Lot NumberCVTH0026
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Device Age15 MO
Event Location Hospital
Initial Date Manufacturer Received 11/06/2013
Initial Date FDA Received01/28/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
11/06/2013
11/06/2013
Supplement Dates FDA Received03/31/2014
01/28/2016
02/24/2016
07/27/2018
01/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/08/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
-
-